DNA Bridges, Inc. Corporate Logo Bridging Science and Products Industry and Client News on Twitter Like Us on Facebook Business Intelligence on LinkedIn
HOMESERVICESABOUT DNA BRIDGES, INC.CLIENTSNEWSROOMCONTACT US

We understand toay's complex markets.

January 7-10, 2013
JP MORGAN HEALTHCARE CONFERENCE
SAN FRANCISCO, CA

February 29 - March 2, 2013
DNA IS PRESENTING A WORKSHOP ON BIOSIMILAR ANTIBODIES
VISP, SWITZERLAND

March 11-13, 2013
BIOEUROPE SPRING
BARCELONA SPAIN

March 11, 2013
Target Health and LifeOnKey Receive BIRD Foundation Award to Integrate the EMR with the EDC Clinical Trial Database

March 14-16, 2013
ST GALLEN BREAST CANCER CONFERENCE

April 22-25, 2013
BIO INTERNATIONAL CONVENTION
CHICAGO, IL

May 21-23, 2013
DNA IS PRESENTING AT BIOEQUITY
STOCKHOLM SWEDEN

May 31 - June 4, 2013
ASCO ANNUAL MEETING
CHICAGO, IL

July 21, 2013
TechnoSTAT Ltd (Israel) and Target HealthInc. (USA)Partner in EDC and the Paperless Clinical Trial

September 24-26, 2013
DNA is presenting “The ABC for ADDCC and CDC at 4TH ANNUAL BIOSPECIFIC ANTIBODY SUMMIT
BOSTON, MA.

September 26 - October 1, 2013
ESMO ANNUAL MEETING, AMSTERDAM, THE NETHERLANDS

October 14-17, 2013
WORLD ADC CONFERENCE, SAN FRANCISCO, CA
       DNA will conduct a workshop on Biological Factors Critical to ADC Drug Discovery and
       Development -

October 22-24, 2013
WORLD CPHI
FRANKFURT, GERMANY

November 4-6, 2013
BIOEUROPE
VIENNA, AUSTRIA

November 19, 2013
to-BBB Awarded European FP7 Funding in Large Consortium Targeting Epilepsy and Epiletogenesis

November 25, 2013
Portola Pharmaceuticals Receives Breakthrough Therapy Designation From FDA for Andexanet Alfa (PRT4445*), Investigational Factor Xa Inhibitor Antidote

December 3, 2013
JHL Biotech, Inc. and Selexis SA Form Biologic Drug Development Alliance to Serve the Biopharmaceutical Industry

 

 



Newsroom

DNA Bridges Articles

Calendar of Events

Archives
  2014  |  2013  |  2012
  2011  |  2010  |  2009  |  2008
  2007  |  2006  |  2005  |  2004
  2003  |  2002  |  2001  |  2000